PPT-Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis: 1-year

Author : megan | Published Date : 2023-12-30

doubleblind placebocontrolled study with openlabel extension Atul Deodhar MD Oregon Health amp Science University Portland OR USA Key message Upadacitinib a JAK1

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Efficacy and safety of upadacitinib in p..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis: 1-year: Transcript


doubleblind placebocontrolled study with openlabel extension Atul Deodhar MD Oregon Health amp Science University Portland OR USA Key message Upadacitinib a JAK1 inhibitor showed sustained and consistent efficacy over 1 year in AS patients. (. Marie-. Strümpell. disease/ . Bechterew's. disease ) . Inflammatory disorder of unknown cause that primarily affects the axial skeleton; peripheral joints and extra-. articular. structures may also be involved .. . Ataman. , . MD. Professor, Rheumatology Division. , . Ankara . University . Medical . Faculty . ISSN: 2329-9126. Rheumatology: Current Research. Research Interests. To contribute to establishment of large-scale registry systems and to make them work. Marie-. Strümpell. disease/ . Bechterew's. disease ) . Inflammatory disorder of unknown cause that primarily affects the axial skeleton; peripheral joints and extra-. articular. structures may also be involved .. Drew Trainor, DO MS FAAPMR FAAPM. dtrainor@denverbackpainspecialists.com. We find what we look for and we look for what we know. Lecture Outline. Case. Epidemiology. Pathophysiology. Clinical manifestations. Seronegative Arthritis Or Spondyloartropaties Introduction Spondyloarthritis or Seronegative Spondyloarthritis Refers to inflammatory changes involving the spine and the spinal joints. Microbiome in Offspring of AS Patients. Associations of HLA-B Alleles, Enthesitis, and Peripheral Arthritis in AS. Associations of HLA-B Alleles, Enthesitis, and Peripheral Arthritis in AS. How Does HLA Type Impact the Pathogenesis of Spondyloarthritis?. . dari. . bahasa. . Yunani. , . dari. kata;. ankylos. . = . melengkung. spondylos. . = . vertebra. Ankylosing . spondylitis . adalah. . penyakit. . inflamasi. . kronis. yang . terutama. . menyerang. Disease Features. Current Management. Spondyloarthropathies (SpA). A cluster of inter-related and overlapping diseases that includes 5 subtypes:. Ankylosing Spondylitis (AS). Reactive Arthritis. Psoriatic Arthritis . Ankylosing. Spondylitis. This program is supported by an . educational . grant from . Novartis Pharmaceuticals Corporation.. Goal of Activities. Provide new information based on breaking medical news, new data presented at medical meetings, and an interactive series of cases on current management strategies on the most up-to-date evidence-based medicine and clinical trial results in . 1 Ankylosing spondylitis Description Ankylosing spondylitis is a form of painful, ongoing joint inflammation (chronic inflammatory arthritis) that primarily affects the spine. Early symptoms of anky Case ReportJ Bone Metab 2013;20:47-50http://dx.doi.org/10.11005/jbm.2013.20.1.47 Osteoporotic Lumbar Compression Fracture in Patient with Ankylosing Spondylitis Treated with KyphoplastyGang Deuk Kim, B. C. Lentle, A. S. Russell, J. S. Percy, and F. I. Jackson w. w. Cross Cancer and University of Alberta, Edmonton, Alberta, Canada A prospective study of bone scintigraphic findings has been carried . . Husham. . Aldaoseri. 12.Oct.2023. Objectives. Introduction. Spondyloarthropathies. . SPA. Seronegative. . Spondyloarthritis. Absence of Rheumatoid Factor or other autoantibody serologic abnormalities:. series- XV -MSK. Contributing radiologists - Dr . Pavankumar. (DMRD, DNB) . Dr . Saarah. khan ( MD) . Dr Anju (MD) . Dr Ashok . sharma. (MD). we support . FOAMrad. - free open access radiology education.

Download Document

Here is the link to download the presentation.
"Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis: 1-year"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents